Home » French Woman Identified as Sole Carrier of New ‘Gwada Negative’ Blood Type

French Woman Identified as Sole Carrier of New ‘Gwada Negative’ Blood Type

by Web Desk
0 comments
blood

In a remarkable medical breakthrough, France’s national blood supply agency, the Établissement Français du Sang (EFS), has identified a French woman from the Caribbean island of Guadeloupe as the sole known carrier of a previously unknown blood type, now officially named “Gwada negative.”

This unprecedented discovery, now recognized globally, marks the 48th officially identified blood group system in the world, following its approval by the International Society of Blood Transfusion (ISBT) in June 2025 in Milan, Italy.

How the Rare Blood Type Was Discovered

The journey began back in 2011, when the woman, then 54 and living in Paris, was undergoing routine pre-surgical blood testing. Doctors detected a mysterious antibody that didn’t match any known blood group at the time.

NHA Successfully Auctions 68 Toll Plazas Nationwide in Transparent Public Bidding

“This antibody was highly unusual and could not be categorized within the existing systems,” explained Thierry Peyrard, a medical biologist at the EFS who played a key role in the discovery.

Due to limited technological resources at the time, research stalled—until 2019, when advancements in high-throughput DNA sequencing enabled scientists to finally crack the genetic code behind the anomaly.

Researchers discovered that the woman had inherited mutated genes from both her mother and father, making her the only known individual with the complete genetic blueprint for “Gwada negative.” As Peyrard put it:

“She is the only person in the world who is compatible with herself.”

What Is “Gwada Negative”?

The name “Gwada negative” was inspired by the woman’s Guadeloupean roots (“Gwada” being a popular nickname for the island) and has been warmly received by the scientific community for its uniqueness and global appeal.

The blood group is genetically distinct and does not fit into the established categories such as ABO, Rh, Kell, Duffy, or MNS systems. Its discovery is not only symbolic of scientific progress but may also represent a new frontier in transfusion medicine, particularly for people with rare or unclassified blood types.

Why This Discovery Matters

The identification of this new blood group holds significant promise for both clinical medicine and genetic research. It can help:

  • Improve transfusion compatibility testing
  • Prevent immune reactions during surgery or childbirth
  • Offer more accurate care to patients with rare blood profiles

The EFS emphasized in its announcement:

“Discovering new blood groups means offering patients with rare blood types a better level of care.”

The Search for More “Gwada Negative” Individuals

Peyrard and his team now hope to identify more carriers of the Gwada negative blood group. The rarity of the mutation suggests that potential carriers could be found through targeted genetic screening in specific populations—particularly those of Caribbean or African descent, where blood diversity is historically under-researched.

In the meantime, the woman remains a medical rarity, a genetic one-of-a-kind, whose blood could one day help develop better diagnostics or tailored treatments for others with similarly rare conditions.


Next Steps in Research:

  • Broaden DNA screening in Afro-Caribbean regions
  • Study the molecular biology of Gwada negative
  • Develop transfusion protocols for ultra-rare blood types

You may also like

Leave a Comment